4SC AG is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical needs. 4SC's own pipeline currently comprises one drug candidate which has met the primary endpoint in the phase II pivotal study (RESMAIN): Kinselby – resminostat.
4SC is headquartered in Planegg-Martinsried near Munich, Germany.
To strengthen our Regulatory Affairs Department in Martinsried near Munich we are seeking to h...